Get in touch with our team to learn more about NovaTechs and our innovative solutions
Urmonderbaan 22, 6167 RD
Geleen, Limburg
The Netherlands
+31 6 4750 3463
info@novatechs.com
Monday - Friday
9:00 AM - 6:00 PM CET
We'd love to hear from you. Please fill out the form below and we'll get back to you as soon as possible.
We're here to help and answer any questions you might have. We look forward to hearing from you.
Visit our office at Brightlands Chemelot Campus
Quick answers to common questions
NovaSeal® is our flagship liquid embolic agent designed to revolutionize cancer treatment through targeted therapy that minimizes collateral damage to healthy tissues while maximizing therapeutic impact on tumors.
We are currently preparing for first-in-human trials, which are expected to begin in 2025. We are conducting comprehensive preclinical studies to ensure patient safety.
While we are not currently recruiting participants, you can register your interest on our Clinical Trials page to receive updates when trials become available.
Yes, we actively seek partnerships with academic institutions, clinical organizations, and industry leaders. Please contact us for partnership opportunities.